CL2015003704A1 - Péptidos y peptidomiméticos en usos de combinación y tratamientos para la subpoblacion de pacientes con cáncer - Google Patents
Péptidos y peptidomiméticos en usos de combinación y tratamientos para la subpoblacion de pacientes con cáncerInfo
- Publication number
- CL2015003704A1 CL2015003704A1 CL2015003704A CL2015003704A CL2015003704A1 CL 2015003704 A1 CL2015003704 A1 CL 2015003704A1 CL 2015003704 A CL2015003704 A CL 2015003704A CL 2015003704 A CL2015003704 A CL 2015003704A CL 2015003704 A1 CL2015003704 A1 CL 2015003704A1
- Authority
- CL
- Chile
- Prior art keywords
- peptidomimetics
- subpopulation
- peptides
- treatments
- cancer patients
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Inorganic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361838777P | 2013-06-24 | 2013-06-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2015003704A1 true CL2015003704A1 (es) | 2016-07-29 |
Family
ID=52141164
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2015003704A CL2015003704A1 (es) | 2013-06-24 | 2015-12-22 | Péptidos y peptidomiméticos en usos de combinación y tratamientos para la subpoblacion de pacientes con cáncer |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US9221872B2 (es) |
| EP (1) | EP3013351B1 (es) |
| JP (1) | JP6401255B2 (es) |
| KR (1) | KR102247493B1 (es) |
| CN (1) | CN105324121A (es) |
| AU (1) | AU2014300713B2 (es) |
| BR (1) | BR112015032542A2 (es) |
| CA (1) | CA2916136C (es) |
| CL (1) | CL2015003704A1 (es) |
| CY (1) | CY1122523T1 (es) |
| DK (1) | DK3013351T3 (es) |
| ES (1) | ES2765300T3 (es) |
| HK (1) | HK1219905A1 (es) |
| HR (1) | HRP20192264T1 (es) |
| HU (1) | HUE046873T2 (es) |
| IL (1) | IL243266B (es) |
| LT (1) | LT3013351T (es) |
| MX (1) | MX366341B (es) |
| MY (1) | MY182232A (es) |
| PH (1) | PH12015502855A1 (es) |
| PL (1) | PL3013351T3 (es) |
| PT (1) | PT3013351T (es) |
| RS (1) | RS60180B1 (es) |
| RU (1) | RU2732440C2 (es) |
| SG (1) | SG11201510490VA (es) |
| SI (1) | SI3013351T1 (es) |
| WO (1) | WO2014207556A1 (es) |
| ZA (1) | ZA201600089B (es) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9273093B2 (en) | 2012-10-11 | 2016-03-01 | Protagonist Therapeutics, Inc. | α4β7 peptide dimer antagonists |
| US9822157B2 (en) | 2013-03-15 | 2017-11-21 | Protagonist Therapeutics, Inc. | Hepcidin analogues and uses thereof |
| DK3143037T3 (da) | 2014-05-16 | 2021-09-20 | Protagonist Therapeutics Inc | Alpha4beta7-integrin-thioether-peptidantagonister |
| EP3169403B1 (en) | 2014-07-17 | 2024-02-14 | Protagonist Therapeutics, Inc. | Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases |
| SG11201702553RA (en) | 2014-10-01 | 2017-04-27 | Protagonist Therapeutics Inc | NOVEL α4β7 PEPTIDE MONOMER AND DIMER ANTAGONISTS |
| EP3201217A4 (en) | 2014-10-01 | 2018-07-18 | Protagonist Therapeutics Inc. | Novel cyclic monomer and dimer peptides having integrin antagonist activity |
| US10787490B2 (en) | 2015-07-15 | 2020-09-29 | Protaganist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| TWI805542B (zh) * | 2015-10-23 | 2023-06-21 | 日商坎巴斯有限公司 | 用於癌症治療之肽及擬肽與ｔ細胞活化劑及／或查核點抑制劑之組合 |
| US10149887B2 (en) * | 2015-10-23 | 2018-12-11 | Canbas Co., Ltd. | Peptides and peptidomimetics in combination with t cell activating and/or checkpoint inhibiting agents for cancer treatment |
| US20190002503A1 (en) | 2015-12-30 | 2019-01-03 | Protagonist Therapeutics, Inc. | Analogues of hepcidin mimetics with improved in vivo half lives |
| CA3017926C (en) | 2016-03-23 | 2023-10-10 | Protagonist Therapeutics, Inc. | Methods for synthesizing .alpha.4.beta.7 peptide antagonists |
| PL3464336T3 (pl) | 2016-06-01 | 2022-05-16 | Athira Pharma, Inc. | Związki |
| EP4092038A1 (en) | 2017-09-11 | 2022-11-23 | Protagonist Therapeutics, Inc. | Opioid agonist peptides and uses thereof |
| US11753443B2 (en) | 2018-02-08 | 2023-09-12 | Protagonist Therapeutics, Inc. | Conjugated hepcidin mimetics |
| CN114341161A (zh) | 2019-07-10 | 2022-04-12 | 领导医疗有限公司 | 白细胞介素-23受体的肽抑制剂及其用于治疗炎症性疾病的用途 |
| JP7441955B2 (ja) | 2020-01-15 | 2024-03-01 | ヤンセン バイオテツク，インコーポレーテツド | インターロイキン２３受容体のペプチド阻害剤および炎症性疾患を治療するためのその使用 |
| MX2023005994A (es) | 2020-11-20 | 2023-08-11 | Janssen Pharmaceutica Nv | Composiciones de inhibidores peptidicos del receptor de interleucina-23. |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100863090B1 (ko) * | 2002-01-17 | 2008-10-13 | 다케다 파머수티컬 컴패니 리미티드 | 항증식 활성을 지니고／지니거나 핵산 손상제 또는 처리제를 증강시키는 펩티드 및 펩티드모방체 |
| PL212929B1 (pl) * | 2002-10-31 | 2012-12-31 | Metabasis Therapeutics Inc | Pochodna cytarabiny, jej zastosowania oraz kompozycja farmaceutyczna zawierajaca ta pochodna |
| US7125842B2 (en) * | 2003-04-07 | 2006-10-24 | Canbas Co. Ltd. | Anti-fungal compounds and methods of use |
| EP1648490A2 (en) * | 2003-06-25 | 2006-04-26 | Canbas Co., Ltd. | Peptides and peptidomimetics having immune-modulating, anti-inflammatory, and anti-viral activity |
| CN102149725A (zh) * | 2008-05-14 | 2011-08-10 | 三井有限公司 | 用于抑制g2细胞周期停滞和使细胞对dna损伤剂敏感的cbp501衍生制剂及基于其的方法 |
-
2014
- 2014-06-24 WO PCT/IB2014/001579 patent/WO2014207556A1/en active Application Filing
- 2014-06-24 KR KR1020157036784A patent/KR102247493B1/ko active IP Right Grant
- 2014-06-24 MX MX2015017609A patent/MX366341B/es active IP Right Grant
- 2014-06-24 JP JP2016520755A patent/JP6401255B2/ja active Active
- 2014-06-24 RU RU2016101718A patent/RU2732440C2/ru active
- 2014-06-24 EP EP14818523.4A patent/EP3013351B1/en active Active
- 2014-06-24 PL PL14818523T patent/PL3013351T3/pl unknown
- 2014-06-24 PT PT148185234T patent/PT3013351T/pt unknown
- 2014-06-24 SG SG11201510490VA patent/SG11201510490VA/en unknown
- 2014-06-24 LT LTEP14818523.4T patent/LT3013351T/lt unknown
- 2014-06-24 RS RS20191687A patent/RS60180B1/sr unknown
- 2014-06-24 CA CA2916136A patent/CA2916136C/en active Active
- 2014-06-24 CN CN201480035471.4A patent/CN105324121A/zh active Pending
- 2014-06-24 ES ES14818523T patent/ES2765300T3/es active Active
- 2014-06-24 DK DK14818523.4T patent/DK3013351T3/da active
- 2014-06-24 US US14/313,264 patent/US9221872B2/en active Active
- 2014-06-24 BR BR112015032542A patent/BR112015032542A2/pt not_active Application Discontinuation
- 2014-06-24 SI SI201431451T patent/SI3013351T1/sl unknown
- 2014-06-24 MY MYPI2015704731A patent/MY182232A/en unknown
- 2014-06-24 AU AU2014300713A patent/AU2014300713B2/en active Active
- 2014-06-24 HU HUE14818523A patent/HUE046873T2/hu unknown
-
2015
- 2015-12-21 IL IL24326615A patent/IL243266B/en active IP Right Grant
- 2015-12-22 CL CL2015003704A patent/CL2015003704A1/es unknown
- 2015-12-22 PH PH12015502855A patent/PH12015502855A1/en unknown
-
2016
- 2016-01-06 ZA ZA2016/00089A patent/ZA201600089B/en unknown
- 2016-07-12 HK HK16108103.9A patent/HK1219905A1/zh unknown
-
2019
- 2019-12-17 HR HRP20192264TT patent/HRP20192264T1/hr unknown
- 2019-12-23 CY CY20191101352T patent/CY1122523T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2015003704A1 (es) | Péptidos y peptidomiméticos en usos de combinación y tratamientos para la subpoblacion de pacientes con cáncer | |
| HK1212363A1 (en) | Peptides for skin rejuvenation and methods of using the same | |
| IL242610A0 (en) | History of pyrazolopyrrolidine and their use in the treatment of diseases | |
| BR302013004536S1 (pt) | Configuração aplicada em curativo médico | |
| SG11201602070TA (en) | Substituted nicotinimide inhibitors of btk and their preparation and use in the treatment of cancer, inflammation and autoimmune disease | |
| HK1221178A1 (zh) | 卡博替尼劑型及其在癌症治療中的使用 | |
| BR302013004565S1 (pt) | Configuração aplicada em curativo médico | |
| CL2016000777A1 (es) | Biomarcadores de cáncer y usos de los mismos | |
| DK3027208T3 (da) | Cancerdiagnose og -terapi, der involverer cancerstamceller | |
| BR302013004419S1 (pt) | Configuração aplicada em instrumento médico | |
| BR112015028115A2 (pt) | métodos e composições para o tratamento de câncer | |
| BR302013006577S1 (pt) | Configuração apliacada em instrumento médico | |
| GB201318170D0 (en) | Proteins with Diagnostic and Therapeutic Uses | |
| DK3044229T3 (da) | Peptider til anvendelse i behandlingen af oral mucositis | |
| BR112016004943A2 (pt) | aparelho médico e uso | |
| EP2853591A4 (en) | HEMATOMIC HEMAZONE CELL LINE HLCZ01 AND USES THEREOF | |
| DE102013202503A8 (de) | Instrument, insbesondere medizinisch-endoskopisches Instrument oder Technoskop | |
| IL245015A0 (en) | Medicinal composition containing icotinib for topical treatment of the skin and its use | |
| ZA201503834B (en) | Identifying subjects in need of treatment | |
| PT3052476T (pt) | Inibidores de nicotinimida substituídos de btk e sua preparação e uso no tratamento do cancro, inflamações e doenças autoimunes | |
| TH1401007652A (th) | อะมิโนไตรอะโซโลไพริดีนสำหรับการใช้ในการรักษาการอักเสบ และองค์ประกอบทางเภสัชกรรมของมัน | |
| TH1501001625A (th) | วิธีการและระบบสำหรับการทรีทเมนท์เนื้อเยื่อทางชีววิทยา | |
| TH1401007936A (th) | วิธีการและระบบสำหรับการทรีทเนื้อเยื่อทางชีววิทยา | |
| ITFI20130304A1 (it) | Bicyclic peptidomimetics for use in the treatment of fungal infections | |
| AP2015008849A0 (en) | Pyrazolopyrrolidine derivatives and their use in the treatment of disease |